227 related articles for article (PubMed ID: 34592700)
1. Sodium channel blockers are effective for benign infantile epilepsy.
Numoto S; Kurahashi H; Takagi M; Azuma Y; Iwayama H; Okumura A
Seizure; 2021 Nov; 92():207-210. PubMed ID: 34592700
[TBL] [Abstract][Full Text] [Related]
2. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
Baulac M; Byrnes W; Williams P; Borghs S; Webster E; De Backer M; Dedeken P
Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of lacosamide in children and young adults previously treated with other sodium channel blockers.
Suzuki T; Natsume J; Kumai S; Maki Y; Yamamoto H; Numoto S; Narahara S; Kubota T; Tsuji T; Kato T; Yamada K; Maruyama K; Okumura A; Takahashi Y; Kidokoro H
Epilepsy Behav; 2021 Dec; 125():108397. PubMed ID: 34814035
[TBL] [Abstract][Full Text] [Related]
5. Mode of seizure inhibition by sodium channel blockers, an SV2A ligand, and an AMPA receptor antagonist in a rat amygdala kindling model.
Wu T; Ido K; Ohgoh M; Hanada T
Epilepsy Res; 2019 Aug; 154():42-49. PubMed ID: 31035244
[TBL] [Abstract][Full Text] [Related]
6. Switching from traditional sodium channel blockers to lacosamide in patients with epilepsy.
Kim DW; Kim HK; Bae EK
Seizure; 2019 Feb; 65():172-175. PubMed ID: 30721874
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of immediate switch from sodium channel blockers to Lacosamide.
Talha Özgün O; Kandemir Yılmaz M; Mert Atmaca M; Keskin Güler S; Buluş E; Duman A; Çelebi Ö; Gürses C
Epilepsy Behav; 2023 Aug; 145():109355. PubMed ID: 37473655
[TBL] [Abstract][Full Text] [Related]
8. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
9. Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort.
McGinnis E; Kessler SK
Epilepsia; 2016 Sep; 57(9):1416-25. PubMed ID: 27430392
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the efficacy and influencing factors of sodium channel blockers in the treatment of focal epilepsy in infants under 6 months of age].
Ma YP; Deng J; Fu ZR; Chen CH; Wang XH; Wang X; Weng JW; Shen YH
Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):983-988. PubMed ID: 37899337
[No Abstract] [Full Text] [Related]
11. Sodium channel blockers for the treatment of epilepsy in CDKL5 deficiency disorder: Findings from a multicenter cohort.
Aledo-Serrano Á; Gómez-Iglesias P; Toledano R; Garcia-Peñas JJ; Garcia-Morales I; Anciones C; Soto-Insuga V; Benke TA; Del Pino I; Gil-Nagel A
Epilepsy Behav; 2021 May; 118():107946. PubMed ID: 33848848
[TBL] [Abstract][Full Text] [Related]
12. Efficacy, Tolerability, and Retention of Antiseizure Medications in
Döring JH; Saffari A; Bast T; Brockmann K; Ehrhardt L; Fazeli W; Janzarik WG; Klabunde-Cherwon A; Kluger G; Muhle H; Pendziwiat M; Møller RS; Platzer K; Santos JL; Schröter J; Hoffmann GF; Kölker S; Syrbe S
Neurol Genet; 2022 Oct; 8(5):e200020. PubMed ID: 36187725
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience combined with therapeutic drug monitoring of lacosamide.
Svendsen T; Brodtkorb E; Baftiu A; Lossius MI; Nakken KO; Johannessen SI; Johannessen Landmark C
Acta Neurol Scand; 2020 Apr; 141(4):279-286. PubMed ID: 31853958
[TBL] [Abstract][Full Text] [Related]
14. PRRT2-positive self-limited infantile epilepsy: Initial seizure characteristics and response to sodium channel blockers.
Lee J; Kim YO; Lim BC; Lee J
Epilepsia Open; 2023 Jun; 8(2):436-443. PubMed ID: 36775847
[TBL] [Abstract][Full Text] [Related]
15. Lacosamide for children with paroxysmal kinesigenic dyskinesia.
Furukawa G; Negishi Y; Takeuchi T; Ishihara N; Okumura A
Brain Dev; 2020 Sep; 42(8):617-620. PubMed ID: 32430160
[TBL] [Abstract][Full Text] [Related]
16. Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur, China.
Zhao T; Li HJ; Ma L; Feng J; Wang TT; Yu J; Sun L; Sun Y; Yu LH
Epilepsy Behav; 2021 Apr; 117():107814. PubMed ID: 33611102
[TBL] [Abstract][Full Text] [Related]
17. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
18. A novel action of lacosamide on GABA
Ruffolo G; Di Bonaventura C; Cifelli P; Roseti C; Fattouch J; Morano A; Limatola C; Aronica E; Palma E; Giallonardo AT
Neurobiol Dis; 2018 Jul; 115():59-68. PubMed ID: 29621596
[TBL] [Abstract][Full Text] [Related]
19. Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy.
Izzi F; Placidi F; Liguori C; Posca I; Lauretti B; Diomedi M; Pisani A; Mercuri NB; Rocchi C
J Neurol Sci; 2020 Nov; 418():117095. PubMed ID: 32841918
[TBL] [Abstract][Full Text] [Related]
20. Equipotency of lacosamide to levetiracetam in new onset focal epilepsy: A randomized controlled trial.
Jaiswal BK; Bhoi SK; Jha M; Samal P; Porey C
J Neurosci Rural Pract; 2023; 14(4):622-628. PubMed ID: 38059231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
